Last edition
News about Ingredients
Hikal Launches New High Potency API Laboratory at its Pune Integrated Innovation Centre
Hikal has inaugurated an advanced High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at its Integrated Innovation Centre in Pune, further strengthening its end-to-end CDMO capabilities and enhancing its ability to safely develop, test and deliver highly potent compounds for the global pharmaceutical industry.
Ingredients | 14/10/2025 | By Dineshwori | 183
Hikal Opens New High Potency API Lab in Pune
Hikal Ltd., a preferred long-term partner to leading global life sciences companies, has inaugurated its state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at the company’s Integrated Innovation Centre in Pune.
Ingredients | 13/10/2025 | By Darshana | 188
Lonza Expands TheraPEAK Product Portfolio, Launches AmpliCell Cytokines and TheraPEAK 293-GT Medium
Switzerland-based Lonza has expanded its GMP solutions for cell and gene therapy with the launch of TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium.
Ingredients | 07/10/2025 | By Dineshwori | 159
Promocell Enters GMP Field with Launch of Custom Cell Culture Media Services
PromoCell GmbH has announced its entry into the Good Manufacturing Practice (GMP) field with the launch of custom cell culture media services designed specifically for cell-based therapy and regenerative medicine.
Ingredients | 01/10/2025 | By Dineshwori | 190
Evonik Expands Excipients Portfolio, Launches MaxiPure Polysorbate 80 for Injectable Formulations
Engineered to meet the stringent demands of modern drug development, Evonik's MaxiPure Polysorbate 80 addresses key challenges such as protein stability, viral inactivation, and the consistent solubilisation of hydrophobic active pharmaceutical ingredients (APIs).
Ingredients | 24/09/2025 | By Dineshwori | 139
The first participant has been dosed in the pivotal Phase III exPDite-2 trial of bemdaneprocel, an investigational cell therapy, while the first European participants have been enrolled in REGENERATE-PD, a Phase II trial of the gene therapy AB-1005.
Ingredients | 23/09/2025 | By Darshana | 224
Kashiv BioSciences and CRISTALIA Partner to Bring Omalizumab Biosimilar to Latin America
Kashiv BioSciences, LLC (Kashiv), a US-based vertically integrated biopharmaceutical company, has entered into a licensing and supply agreement with CRISTÁLIA, one of Brazil’s leading pharmaceutical companies, to commercialize ADL-018 / bOmalizumab, a proposed biosimilar to Xolair, in Latin America (LATAM).
Ingredients | 14/09/2025 | By Darshana | 275
The Bulk Drug Park at Una in Himachal Pradesh has received environmental clearance from the Union Ministry of Environment, Forest and Climate Change, a key milestone for India’s pharmaceutical infrastructure.
Ingredients | 13/09/2025 | By Darshana | 390
BioNxt Begins Lab-Scale ODF Development After Receiving Semaglutide API
BioNxt Solutions has received the Semaglutide active pharmaceutical ingredient (API), enabling the initiation of laboratory-scale formulation and testing of its oral dissolvable film (ODF) delivery system.
Ingredients | 03/09/2025 | By Dineshwori | 361
India Emerges as Global Manufacturing Powerhouse in Life Sciences: EY Report
India is fast becoming a global hub for life sciences Global Capability Centres (GCCs), according to the latest EY report. Nearly half of the world's top 50 life sciences firms now operate GCCs in the country, amounting to around 100 centres, with plans to scale this number to 160 over the next five years.
Ingredients | 03/09/2025 | By Darshana | 205
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy